HXR9 was also evaluated in AMLs based on the relevance of HOXA9 and PBX3 interaction in AML [29,75,248,249], but other expressed HOX/PBX3 interfaces may also be disrupted by HXR9 in AML. The gene discussed is PBX3; the disease is acute myeloid leukemia.